▲ SIGMATERMINAL Open Terminal →

Analyses / BBBY

BBBY Bed Bath & Beyond Inc As of Jul 6, 2026
$5.83

Penny-near territory with negative margins, heavy insider buying, and M&A pivot—high risk, speculative recovery play.

Setup: recovery_speculative Confidence: 35 Horizon: 6-12 months Risk: very_high Category: penny
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals BBBY's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Insider accumulation (56 buys vs 49 sells; 3.96M vs 0.78M shares) signals conviction. TwoPonds acquisition ($42.3M) expands brand ecosystem; Affirm integration broadens payment options, may drive traffic. P/S 0.42 is cheap. If turnaround gains traction, stock could retest $10–12 in 6–12mo. Current price ~$5.80 is off 52-wk high of $12.65.

▼ Bear Case

Fundamentals are brutal: –18.5% YoY revenue decline, –8.1% net margin, –5.86% operating margin. P/B 1.73 for a loss-making retailer is sketchy. Tangible book $2.50 vs $5.83 price—significant haircut risk. TwoPonds & Affirm moves are small relative to core challenge: same-store sales, foot traffic, competitive pressure. Debt load & interest coverage unclear. Bankruptcy tail risk if turnaround stalls.

Valuation

deeply_distressed — score 28/100

Stock trades below book on a loss-making model. P/B 1.73 unjustifiable for negative ROE; P/S 0.42 is cheap but reflects revenue collapse. Only actionable if turnaround credible—which is priced in by insider accumulation, not by fundamental recovery yet.

Technical Levels

Support · $4.26 (52-week low) · $5.70 (today's low) · $5.50 (near-term support)

Resistance · $6.32 (today's high) · $7.00 (psychological level) · $12.65 (52-week high)

RSI: data not available

Financial Health

Score 32/100. Liquidity (current/quick ratios ~1.2–1.17) is barely adequate; can cover short-term obligations but no buffer for prolonged losses. Profitability severely negative at operating & net levels. Gross margin 24.65% is compressed; unable to cover SG&A. Without revenue stabilization and margin recovery, cash burn continues and refinancing risk rises.

Catalysts

Affirm rollout across brandsImmediate (already announced)Medium—can improve conversion if Buy-Now-Pay-Later removes payment friction; monitor sales for lift.
TwoPonds integrationNext 2–3 quartersMedium—consolidates brand portfolio; success depends on synergy realization and no further dilution.
Quarterly earnings (next report)~6–8 weeksHigh—will show if revenue decline slowed, if margins improved, and if cash burn accelerated or decelerated.
Holiday season salesQ4 2024High—traditional strength period; will signal customer engagement & whether initiatives are working.
Debt refinancing / covenant testsOngoing / next 12 monthsCritical—if company fails to refinance or breaches covenants, equity collapse likely.

Risk Flags

Negative net margin (–8.1%), operating margin (–5.86%); profitable exit unlikely unless turnaround succeeds.
Beta 2.86—extreme volatility; 1% market move = ~2.9% BBBY move. Suitable for risk-tolerant traders only.
P/B 1.73 with net losses; tangible book $2.50—substantial downside if equity is marked down.
Revenue declining –18.5% YoY; structural retail headwinds (e-commerce, consumer spending) ongoing.
Insider buying encouraging, but not a guarantee; executives can be wrong or have different time horizons.

See BBBY's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock BBBY free →

Recent News

More Analyses

BBBY FAQ

Is BBBY a buy right now?

Bed Bath & Beyond Inc's current read is a recovery_speculative setup with 35 confidence over a 6-12 months horizon. Valuation: deeply_distressed. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is BBBY overvalued?

deeply_distressed (valuation score 28/100). Stock trades below book on a loss-making model. P/B 1.73 unjustifiable for negative ROE; P/S 0.42 is cheap but reflects revenue collapse. Only actionable if turnaround credible—which is priced in by insider accumulation, not by fundamental recovery yet.

What are the risks of buying BBBY?

Fundamentals are brutal: –18.5% YoY revenue decline, –8.1% net margin, –5.86% operating margin. P/B 1.73 for a loss-making retailer is sketchy. Tangible book $2.50 vs $5.83 price—significant haircut risk. TwoPonds & Affirm moves are small relative to core challenge: same-store sales, foot traffic, competitive pressure. Debt load & interest coverage unclear. Bankruptcy tail risk if turnaround stalls.